Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 16, 2026

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells
08:36

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

Molecular imaging in oncology.

Egesta Lopci1, Stefano Fanti

  • 1Nuclear Medicine Unit, Humanitas Cancer Center, Rozzano, MI, Italy.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|November 27, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liquid Biopsies and Molecular Imaging for Precise Cancer Management.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Blood advances·2026
Same author

Imaging Immunotherapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same author

Functional-anatomic integration by CCTA and exercise SPECT in adults with anomalous aortic origin of a coronary artery.

International journal of cardiology·2026
Same author

Cost Analysis of PSMA-PET in the PROSPET-BX Trial.

Cancers·2026

While fluorine-18 fluorodeoxyglucose (FDG) is key for cancer imaging, new positron emission tomography (PET) tracers are vital for evaluating other diseases. This review highlights impactful non-FDG PET tracers in clinical practice.

Area of Science:

  • Nuclear Medicine
  • Radiopharmaceutical Chemistry
  • Medical Imaging

Background:

  • Fluorine-18 fluorodeoxyglucose (FDG) is the primary positron emission tomography (PET) tracer for clinical applications, predominantly in oncology.
  • Limitations of FDG necessitate the development of more specific PET tracers for accurate diagnosis of various diseases.
  • The field has seen extensive development of novel radiopharmaceuticals, yet few achieve routine clinical relevance.

Purpose of the Study:

  • To review selected non-FDG PET tracers.
  • To discuss the clinical introduction and impact of these tracers.
  • To provide an overview of PET imaging advancements beyond FDG.

Main Methods:

  • Literature review of non-FDG PET tracers.
  • Analysis of clinical adoption and diagnostic utility.

More Related Videos

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Related Experiment Videos

Last Updated: May 16, 2026

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells
08:36

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

  • Focus on tracers with established or emerging clinical significance.

    • Main Results:

    • Several non-FDG PET tracers have been developed and introduced into clinical practice.
    • These tracers offer improved diagnostic capabilities for specific diseases not well-visualized by FDG.
    • The impact varies, with some tracers gaining significant traction in routine medical imaging.

    Conclusions:

    • Non-FDG PET tracers are crucial for expanding the diagnostic scope of PET imaging.
    • Continued development and clinical validation are essential for advancing personalized medicine.
    • The selection of appropriate PET tracers significantly influences diagnostic accuracy and patient management.